Abiraterone Acetate 250 mg: Revolutionizing Prostate Cancer Treatment
Abiraterone acetate 250 mg is a widely recognized medication primarily used in the treatment of metastatic castration-resistant prostate cancer (mCRPC). This guide explores its uses, mechanism of action, dosage, potential side effects, and important considerations for patients and healthcare providers. What is Abiraterone Acetate? Abiraterone